Net Cash Provided by (Used in) Operating Activities |
52.8M |
USD |
-52.1% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
48.3M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-167M |
USD |
-291% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
450M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
142M |
shares |
+0.59% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
110M |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
161M |
USD |
-51.4% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
116M |
USD |
+29.4% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
50M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
8.92M |
USD |
+124% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Share-based Payment Arrangement, Expense |
17.3M |
USD |
-3.56% |
Mar 31, 2024 |
Q1 2024 |
Interest Expense |
489M |
USD |
+48.1% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |